scorecardresearch
Add as a preferred source on Google
Monday, October 5, 2026

Support our Journalism

9th Anniversary: Free Tote & Mug

Subscribe
TopicDGCI

Topic: DGCI

Why medical device makers are peeved with Modi govt’s new Drugs Bill

The proposed Draft Drugs, Medical Devices and Cosmetics Bill, 2026 seeks to replace the Drugs and Cosmetics Act, 1940, with a new law for drugs, medical devices and cosmetics.

India’s next DCGI: Recruitment opens despite legal challenge to revised eligibility norms

The Centre has expanded the eligibility criteria to include engineering disciplines, but serving drug inspectors say the new rules dilute the qualifications for the post.

Months after import duty waiver, GST slashed on same 3 anti-cancer drugs. Why this is little relief

Centre moves to reduce costs of trastuzumab deruxtecan, osimertinib & durvalumab, all 3 by British-Swedish pharma giant AstraZeneca. Doctors seek exemptions for more such drugs. 

Tough pill to swallow for e-pharmacies as govt’s draft bill proposes curbs on online sale of drugs

Likely to be presented to Cabinet before being tabled in Parliament, latest version of draft bill aims to regulate, restrict or ban online sale of prescription drugs.

Texas hospital’s Covid-19 vaccine Corbevax is ‘not for profit’. It’s a ‘gift to the world’

In a statement, Biological E. said it plans to manufacture 75 million doses a month, anticipating more than 100 million doses per month by February 2022.

France’s Sanofi seeks marketing nod for dengue vaccine, govt panel says identify endemic areas

The vaccine Dengvaxia has to be administered to individuals aged 9 to 45, who have been infected with the dengue virus before and who live in areas where this infection is endemic.

DCGI’s Covaxin ‘approval’ is political jumla. It reinforces idea of Modi’s Atmanirbhar Bharat

The Modi govt must not damage India’s competitive advantage in vaccines & pharmaceuticals through absurd benchmarks that will not be trusted by other countries.

Covaxin & Covishield get govt nod for emergency use, stage set for Covid immunisation to begin

Drugs Controller General of India has granted 'conditional approval' to the vaccine candidates. A third candidate by Cadila Healthcare has got nod to conduct Phase III clinical trial.

All about Biocon’s Itolizumab, psoriasis drug approved for emergency use in Covid patients

DGCI has given 'restricted emergency use' approval to the drug for treating Covid-19 patients with moderate-to-severe acute respiratory distress.

On Camera

Role reversal? Congress is adopting BJP’s best practices as the latter learns the worst

The BJP’s drift contrasts sharply with Rahul Gandhi’s organisational push, street politics and growing appeal among young voters.

Bloomberg’s oil columnist got an EV. A bad omen for big petroleum?

For as long as the Mid East & Russia-Ukraine wars continue, the trajectory of future oil consumption will matter little. What’s important today is the flow of barrels, writes Javier Blas.

Drones for IAF are not revolutionary but evolutionary, says IAF chief

IAF chief Air Chief Marshal A.P. Singh has ruled out a separate drone force, saying that UAVs must operate with fighters and other existing technology.

India has always been a hard state under Gandhian cover. Nehru to Modi, leaders have reinforced it

Modern India might have been conjured up in the image of Gandhi. But India was never a Gandhian state. Founders of the Republic, be it Nehru or Patel, nursed zero such notions.